Earnings History Data for Penumbra, Inc. (PEN) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Penumbra, Inc.

Penumbra, Inc. is an interventional therapies company. It designs, develops, manufactures and markets medical devices. The company's portfolio of products primarily addresses neuro and peripheral vascular medical conditions and clinical needs. Neuro products include Neurovascular Access, Neuron Access System, BENCHMARK Intracranial Access System, Penumbra System, 3D, Penumbra Coil 400, Penumbra SMART Coil and LIBERTY stent. Peripheral vascular products include Ruby Coil System, Penumbra Occlusion Device and Indigo System. It operates primarily in U.S., Europe, Canada and Australia. Penumbra, Inc. is headquartered in Alameda, California.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
23-04-2025	AH		PEN	Penumbra, Inc.	10,420	0.83	0.66	0.41	Penumbra Non-GAAP EPS of $0.83 beats by $0.16, revenue of $324.1M beats by $8.37M [4/23/2025 4:15 PM]	298.04	19.27 (6.91%)	278.77	0.0 (0.00%)	148.00 - 310.00	1,414,984	510,000	9,277,578
Penumbra Non-GAAP EPS of $0.83 beats by $0.16, revenue of $324.1M beats by $8.37M [4/23/2025 4:15 PM] Penumbra projects 12%-14% revenue growth for 2025 amid strong thrombectomy performance [4/23/2025 8:16 PM] Penumbra, Inc. Reports First Quarter 2025 Financial Results [2025-04-23 04:05PM] Stroke Management Drug Firm Climbs To Key Level Ahead Of Earnings; But Beware This Pharma Tariff [Apr-22-25 01:04PM] What To Expect From Penumbra's (PEN) Q1 Earnings [Apr-22-25 08:04AM]
18-02-2025	AH		PEN	Penumbra	10,473	0.97	0.91	0.00	Penumbra GAAP EPS of $0.86 misses by $0.04, revenue of $315.52M beats by $3.89M [2/18/2025 4:09 PM]	302.80	31.66 (11.68%)	294.02	22.88 (8.44%)	148.00 - 310.00	1,615,416	470,000	8,649
Penumbra GAAP EPS of $0.86 misses by $0.04, revenue of $315.52M beats by $3.89M [2/18/2025 4:09 PM] Penumbra targets 13%-14% revenue growth for 2025 with focus on thrombectomy market expansion [2/18/2025 11:05 PM] Penumbra, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results [2025-02-18 04:05PM] Penumbra (PEN) Reports Q4: Everything You Need To Know Ahead Of Earnings [Feb-17-25 08:06AM]
30-10-2024	AH		PEN	Penumbra, Inc.	8,110	0.85	0.69	0.67	Penumbra GAAP EPS of $0.75, revenue of $301M [10/30/2024 5:33 PM]	230.60	19.31 (9.14%)	205.00	-6.29 (-2.98%)	148.00 - 277.34	787,060	360,000	250
Penumbra GAAP EPS of $0.75, revenue of $301M [10/30/2024 5:33 PM] Penumbra: Q3 Earnings Snapshot [2024-10-30 04:24PM] Penumbra, Inc. Reports Third Quarter 2024 Financial Results [2024-10-30 04:05PM] Penumbra Inc (PEN) Q3 2024 Earnings Call Highlights: Strong U.S. ... [2024-10-31 03:15AM] Penumbra (PEN) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates [Oct-30-24 06:30PM] Penumbra (PEN) Q3 Earnings and Revenues Top Estimates [Oct-30-24 05:30PM]
30-07-2024	AH		PEN	Penumbra, Inc.	7,370	0.64	0.56	0.43	Penumbra Non-GAAP EPS of $0.64 beats by $0.08, revenue of $299.4M beats by $1.49M [7/30/2024 4:11 PM]	166.97	-6.12 (-3.54%)	149.98	-23.11 (-13.35%)	148.00 - 310.51	2,211,242	470,000	18,223
Penumbra Non-GAAP EPS of $0.64 beats by $0.08, revenue of $299.4M beats by $1.49M [7/30/2024 4:11 PM]
07-05-2024	AH		PEN	Penumbra	7,986	0.41	0.42	0.00	Penumbra Non-GAAP EPS of $0.41 beats by $0.03, revenue of $278.7M beats by $4.2M [5/7/2024 4:27 PM]	203.47	-6.53 (-3.11%)	205.00	-5.00 (-2.38%)	180.93 - 348.67	809,339	370,000	121
Penumbra Non-GAAP EPS of $0.41 beats by $0.03, revenue of $278.7M beats by $4.2M [5/7/2024 4:27 PM]
22-02-2024	AH		PEN	Penumbra, Inc.	10,440	0.76	0.71	0.16	Penumbra GAAP EPS of $1.38 beats by $0.67, revenue of $284.7M misses by $1.83M [2/22/2024 4:38 PM]	238.53	-24.15 (-9.19%)	240.00	-22.68 (-8.63%)	180.93 - 348.67	1,199,276	280,000	43,805
Penumbra GAAP EPS of $1.38 beats by $0.67, revenue of $284.7M misses by $1.83M [2/22/2024 4:38 PM] Penumbra cut to Hold at J.P. Morgan on first revenue miss [2/23/2024 12:46 PM]
02-11-2023	AH		PEN	Penumbra, Inc.	7,350	0.67	0.46	0.01	Penumbra GAAP EPS of $0.23 [11/2/2023 4:15 PM]	197.77	-0.49 (-0.25%)	187.00	-11.26 (-5.68%)	144.76 - 348.67	804,411	330,000	21,743
Penumbra GAAP EPS of $0.23 [11/2/2023 4:15 PM]
01-08-2023	AH		PEN	Penumbra, Inc.	11,780	0.43	0.28	0.01	Penumbra GAAP EPS of $0.48 beats by $0.20, revenue of $261.5M beats by $8.25M [8/1/2023 4:19 PM]	269.18	-29.15 (-9.77%)	270.00	-28.33 (-9.50%)	139.03 - 348.67	1,519,965	380,000	11,698
Penumbra GAAP EPS of $0.48 beats by $0.20, revenue of $261.5M beats by $8.25M [8/1/2023 4:19 PM]
02-05-2023	AH	4:05 PM ET (May 2)	PEN	Penumbra, Inc.	10,830	0.23	0.11	-0.01	Penumbra Q1 results beat estimates, co raises FY 2023 revenue guidance [5/2/2023 4:40 PM]	300.48	19.15 (6.81%)	275.00	-6.33 (-2.25%)	114.86 - 306.70	994,364	390,000	56,521
Penumbra Q1 results beat estimates, co raises FY 2023 revenue guidance [5/2/2023 4:40 PM]
23-02-2023	AH	4:05 PM ET (Feb 23)	PEN	Penumbra, Inc.	10,050	0.16	0.14	0.10	Penumbra Non-GAAP EPS of $0.16 beats by $0.01, revenue of $221.22M beats by $4.19M [2/23/2023 4:37 PM]	267.06	5.34 (2.04%)	261.72	0.0 (0.00%)	114.86 - 269.19	939,109	350,000	6,424
Penumbra Non-GAAP EPS of $0.16 beats by $0.01, revenue of $221.22M beats by $4.19M [2/23/2023 4:37 PM]
03-11-2022	AH	4:05 PM ET (Nov 3)	PEN	Penumbra, Inc.	6,130	0.01	-0.01	0.12	Penumbra Non-GAAP EPS of $0.01 in-line, revenue of $213.7M beats by $1.38M [11/3/2022 4:27 PM]	161.75	9.87 (6.50%)	145.00	-6.88 (-4.53%)	114.86 - 290.36	1,282,969	380,000	1,741
Penumbra Non-GAAP EPS of $0.01 in-line, revenue of $213.7M beats by $1.38M [11/3/2022 4:27 PM] Penumbra upgraded at Citi given upcoming vascular device launches [11/4/2022 11:53 AM]
04-08-2022	AH	4:05 PM ET (Aug 4)	PEN	Penumbra, Inc.	4,950	0.01	-0.07	0.21	Penumbra GAAP EPS of -$0.10 misses by $0.11, revenue of $208.34M beats by $2.1M [8/4/2022 4:52 PM]	166.83	23.69 (16.55%)	166.83	0.0 (0.00%)	114.86 - 293.19	1,333,448	350,000	2,157
Penumbra GAAP EPS of -$0.10 misses by $0.11, revenue of $208.34M beats by $2.1M [8/4/2022 4:52 PM]
03-05-2022	AH	4:05 PM ET (May 3)	PEN	Penumbra	6,595	-0.01	0.06	0.00	Penumbra Non-GAAP EPS of -$0.01 misses by $0.05, revenue of $203.9M beats by $8.51M [5/3/2022 4:23 PM]	171.51	-2.64 (-1.52%)	175.00	0.85 (0.49%)	160.75 - 320.00	482,667	240,000	3,736
Penumbra Non-GAAP EPS of -$0.01 misses by $0.05, revenue of $203.9M beats by $8.51M [5/3/2022 4:23 PM] Penumbra, Inc. Reports First Quarter 2022 Financial Results [May-03-22 04:05PM] Penumbra (PEN) Reports Q1 Loss, Tops Revenue Estimates [May-03-22 06:15PM] Despite Seeing Accelerated 2023 Growth, This Analyst Cut Penumbra's Price Target - Here's Why [May-04-22 03:54PM]
22-02-2022	AH	4:05 PM ET (Feb 22)	PEN	Penumbra, Inc.	8,080	0.10	0.19	0.42	Penumbra GAAP EPS of -$0.66 misses by $0.30, revenue of $204M beats by $9.71M [2/22/2022 4:12 PM]	204.02	-12.57 (-5.80%)	215.00	-1.59 (-0.73%)	193.62 - 320.00	547,423	140,000	3,509
Penumbra GAAP EPS of -$0.66 misses by $0.30, revenue of $204M beats by $9.71M [2/22/2022 4:12 PM] Penumbra, Inc. Reports Fourth Quarter and Full Year 2021 Financial Results [Feb-22-22 04:05PM] Penumbra (PEN) Q4 Earnings Lag Estimates [Feb-22-22 05:55PM] Wall Street Analysts Believe Penumbra (PEN) Could Rally 40%: Here's is How to Trade [Feb-23-22 10:00AM]
03-11-2021	AH	4:05 PM ET (Nov 3)	PEN	Penumbra, Inc.	10,410	0.12	0.17	0.06	Penumbra EPS misses by $0.05, beats on revenue [11/3/2021 4:29 PM]	287.98	10.64 (3.84%)	288.00	0.02 (0.01%)	163.49 - 320.00	342,428	110,000	2,306
Penumbra EPS misses by $0.05, beats on revenue [11/3/2021 4:29 PM] Notable Penumbra Insider Makes $250K Sale [Nov-03-21 11:28AM] Penumbra, Inc. Reports Third Quarter 2021 Financial Results [Nov-03-21 04:05PM] Penumbra (PEN) Lags Q3 Earnings Estimates [Nov-03-21 06:35PM] Penumbra, Inc (PEN) Q3 2021 Earnings Call Transcript [Nov-03-21 11:00PM]
09-08-2021	AH	4:05 PM ET (Aug 9)	PEN	Penumbra, Inc.	9,860	0.21	0.19	-0.30	Penumbra EPS beats by $0.04, beats on revenue [8/9/2021 4:14 PM]	257.98	-5.67 (-2.15%)	270.00	6.35 (2.41%)	163.49 - 320.00	554,984	180,000	2,144
Penumbra EPS beats by $0.04, beats on revenue [8/9/2021 4:14 PM] Penumbra, Inc. Reports Second Quarter 2021 Financial Results [Aug-09-21 04:05PM] Penumbra (PEN) Tops Q2 Earnings and Revenue Estimates [Aug-09-21 06:05PM] Penumbra Introduces REAL® i-Series, Expanding REAL Immersive System to Support Broad Range of Care Providers and Mental Health Professionals [Aug-10-21 09:00AM]
04-05-2021	AH	4:05 PM ET (May 4)	PEN	Penumbra, Inc.	11,300	0.27	0.11	0.00	Penumbra EPS beats by $0.18, beats on revenue [5/4/2021 4:12 PM]	273.41	-15.52 (-5.37%)	273.41	0.0 (0.00%)	161.11 - 320.00	679,592	210,000	3,576
Penumbra EPS beats by $0.18, beats on revenue [5/4/2021 4:12 PM] Penumbra, Inc. to Host Earnings Call [May-04-21 02:30PM] Penumbra, Inc. Reports First Quarter 2021 Financial Results [May-04-21 04:05PM] Penumbra (PEN) Q1 Earnings and Revenues Surpass Estimates [May-04-21 07:55PM] Penumbra Inc (PEN) Q1 2021 Earnings Call Transcript [May-04-21 10:30PM]
23-02-2021	AH	4:05 PM ET (Feb 23)	PEN	Penumbra, Inc.	10,170	0.42	-0.08	0.22	Penumbra EPS beats by $0.48, beats on revenue [2/23/2021 4:12 PM]	288.32	7.72 (2.75%)	290.00	9.39 (3.35%)	121.80 - 314.22	792,315	373,337	7,352
Penumbra EPS beats by $0.48, beats on revenue [2/23/2021 4:12 PM] Investor Alert: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Securities Fraud Class Action Lawsuit Filed Against Penumbra, Inc. (PEN) [Feb-24-21 02:17PM] DEADLINE ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Penumbra, Inc. and Encourages Investors with Losses to Contact the Firm [Feb-24-21 11:25AM] The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of PEN, TCDA and JFU [Feb-23-21 08:11PM] Penumbra: Q4 Earnings Insights [Feb-23-21 04:32PM] Penumbra, Inc. Reports Fourth Quarter and Full Year 2020 Financial Results [Feb-23-21 04:05PM] Kessler Topaz Meltzer & Check, LLP Announces a Securities Fraud Class Action Filed Against Penumbra, Inc. [Feb-23-21 03:52PM] The Gross Law Firm Announces Class Actions on Behalf of Shareholders of PEN, TCDA and BTBT [Feb-23-21 03:10PM] INVESTOR ACTION NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Penumbra, Inc. and Encourages Investors with Losses in Excess of $500,000 to Contact the Firm [Feb-23-21 02:49PM] HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Reminds Penumbra (PEN) Investors of Securities Fraud Lawsuit, Encourages Investors with Losses to Contact its Attorneys Now [Feb-23-21 02:36PM] Penumbra, Inc. to Host Earnings Call [Feb-23-21 02:30PM] CLASS ACTION UPDATE for PEN, JFU and CLSK: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders [Feb-23-21 11:45AM] INVESTOR ACTION NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Penumbra, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm [Feb-23-21 11:20AM] DECN, PEN & WMT Class Actions: Bronstein, Gewirtz & Grossman LLC Reminds Shareholders of Class Actions and Encourages Investors to Contact the Firm [Feb-23-21 11:00AM] LAWSUITS FILED AGAINST PEN, QS and FUBO -Jakubowitz Law Pursues Shareholders Claims [Feb-23-21 06:30AM]
28-10-2020	AH	4:05 PM ET (Oct 28)	PEN	Penumbra, Inc.	8,520	0.06	-0.13	0.25	Penumbra EPS beats by $0.14, beats on revenue [10/28/2020 4:25 PM]	264.18	31.46 (13.52%)	255.00	22.28 (9.57%)	121.80 - 277.00	1,353,275	385,905	1,518

03-08-2020	AH	4:05 PM ET (Aug 3)	PEN	Penumbra, Inc.	8,070	-0.30	-0.48	0.27	Penumbra EPS beats by $0.09, beats on revenue [8/3/2020 4:12 PM]	224.23	-5.25 (-2.29%)	229.48	0.0 (0.00%)	121.80 - 230.86	209,613	258,352	4,293